Approval of the modified Opioid Analgesic REMS is expected in 2024.
The final rule takes effect in 60 days and consumers will be able to purchase hearing aids directly from stores or online retailers as soon as mid-October.
Individual consumers are not restricted from having or using JUUL products; however, the Agency will ensure compliance by retailers.
Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
The American College of Cardiology has issued a policy statement regarding civility, inclusion, and respect in the cardiovascular workplace.
The Strategy focuses on 2 main drivers of the opioid epidemic: drug trafficking and untreated addiction.
The Agency is currently seeking public comment on this potential modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy.
The guidance aims to ensure that the data submitted to the Agency adequately represent the patients that will use the medical products.
Researchers conducted a study that compared voter turnout between physicians and the general population for US elections held between 2000 and 2020.
During the workshop, speakers and panelists reviewed past programs that were put into place to reduce opioid prescribing, as well as trends in opioid prescribing and overdose deaths.
The researchers conducted 1103 surveys, encompassing 464 US physicians.
Murthy plans to focus on COVID-19, mental health, and substance use disorders.
This action was in response to an executive order issued on August 6, 2020 aimed at protecting the public against outbreaks of emerging diseases and chemical, biological, radiological, and nuclear threats.
A survey presented during ASCO20 found that patients who considered themselves adequately informed felt “in control” most days.
Regardless of the challenges a smaller group might have, a risk assessment is a baseline for any HIPAA program. The cost of this assessment is considerably less than a HIPAA fine.
Patients hospitalized with COVID-19 are more often male and frequently have comorbidities.
In an effort to prevent the United States from again struggling to have enough medical supplies in a pandemic, the federal government is seeking to make a five-year deal with U.S. manufacturers.
The number of mask makers in China approved to make N95-type masks for U.S. health care workers was slashed from 80 to 14 by the FDA on Thursday.
This study focused on a cohort of nonelderly Medicaid beneficiaries with stage IV breast or colorectal cancer who resided in New Jersey.
Among 121 healthcare personnel exposed to a patient with unrecognized COVID-19, 43 became symptomatic and 3 tested positive for SARS-CoV-2.